Charlie Altfillisch, MD

University of Kansas Medical Center

Poster(s):

• P2027 - Perforation Risk Versus Mortality Benefit: The Quandary of Rituximab in Treating Post-transplant Lymphoproliferative Disorder
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET

• P2297 - Russell Body Esophagitis Without Associated Barrett’s Esophagus: One of Two Reported Cases
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET

• P3367 - A Rare Approach to a Rarer Diagnosis: Managing Idiopathic Hypertrophic Pyloric Stenosis With Botulinum Toxin
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET